CSL Appoints New Director

CSL Appoints New Director

Melbourne, Australia — 02/09/2008

CSL today announced that Mr David Anstice has been appointed a Director of the Company effective 2 September 2008.

Mr Anstice was a senior executive of Merck & Co, Inc, for many years, retiring as 1 September 2008. Mr Anstice served as President of Merck Human Health for the US/Canada, Europe, Japan and Asia, in separate assignment. He has also been responsible for Merck's prescription drug business in Latin America, Australia and New Zealand, and its joint venture relationshio with Schering Plough.

Download this release: CSL Appoints New Director

For further information, please contact:

Media Contacts
Dr Rachel David
Director of Public Affairs
Phone: 0401 775 779

Investor Contact
Mark Dehring
Director of Investor Relations
Phone: +61 3 9389 2818
Email: mark.dehring@csl.com.au
© 2017 CSL Limited